David Weill
Director · 3 filings · Latest: Sep 11, 2026
TransMedics Group, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TMDX | David Weill | Director | Sep 11, 2026 | Purchase | $81.63 | 1,336 | $109.1K | 16,392 | |
TMDX | David Weill | Director | Mar 4, 2026 | Sale | $146.82 | 3,571 | $524.3K | 12,134 | |
TMDX | David Weill | Director | Mar 4, 2026 | Option Exercise | $14.20 | 3,571 | $50.7K | 15,705 | |
TMDX | DAVID WEILL | — | Mar 4, 2026 | Proposed Sale | $146.82 | 3,571 | $524.3K | — | |
TMDX | DAVID WEILL | — | Dec 3, 2025 | Proposed Sale | $138.64 | 5,000 | $693.2K | — | |
TMDX | DAVID WEILL | — | May 23, 2025 | Proposed Sale | $123.88 | 732 | $90.7K | — |